Followers | 437 |
Posts | 42954 |
Boards Moderated | 2 |
Alias Born | 05/08/2006 |
Friday, August 21, 2015 4:21:40 PM
Medical cannabis and cannabinoid-based therapies are gaining wider acceptance around the United States. More than 20 states and the District of Columbia have legalized the drug and, between 2009 and 2014, IBISWorld estimates that the medical cannabis industry grew significantly to reach $2 billion in revenue. Despite this industry boom and the pioneers that emerged within it, there has been a shortage of companies conducting legitimate research and development and/or with the right amount of scientific backing and funding needed to compete in the industry.
GrowBLOX Sciences, a biopharmaceutical research and development company, stands out from the pack with its advanced technologies in plant biology and cultivation. Led by an impressive scientific team that includes big data experts, the company has turned its attention to creating safe, standardized pharmaceutical-grade cannabis-based therapies that target an assortment of medical conditions. The company is focused on bringing relief to patients in communities across the country by combining ground-breaking technology and industry processes with its “big” data-driven clinical research and development loop ability. Moreover, through its Puerto Rico subsidiary, GrowBLOX Sciences is developing and dispensing its suite of cultivation and growing chambers worldwide.
With its novel approach to using big data to produce lower-risk clinical trial candidates, GrowBLOX is highlighting its strong long-term potential. With over 180 cannabis-related human trials registered with the National Institute of Health (NIH) and more on the way, the company has established a brilliant starting point with close to a thousand potential combinations within the cannabinoid-related therapy space.
In the short term, the company intends to earn revenue from selling certified raw materials through dispensaries. These near-term plans were set in May when the company announced the formation of GrowBLOX Sciences Puerto Rico, a subsidiary that will legally grow cannabis raw materials that will be sold solely to its parent company for dispersion in the U.S. and other countries where the drug is legal.
The company’s operations – cultivation, post-processing and manufacturing – create a model platform to execute these visions. On the cultivation side, its TissueBLOX, GrowBLOX and CureBLOX platforms facilitate the efficient growing of cannabis, while its ExtractionLab produces proprietary blends for distribution as pharmaceuticals, nutraceuticals and cosmeceuticals. Given its distinctive business model, long-term potential in pharmaceuticals and short-term potential in raw material sales, GrowBLOX Sciences is a company worth a closer look.
For more information, visit the company’s website at www.growblox.com
Recent GBLX News
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 08/30/2024 09:13:41 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2024 09:24:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/16/2024 07:12:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/12/2024 09:39:05 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 10:07:34 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 10/10/2023 02:00:29 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM